SCIE期刊Drug Design Development and Therapy 2024/2025影响因子:4.741 (DRUG DES DEV THER) (1177-8881). (PHARMACOLOGY & PHARMACY

显示全部楼层 · 发表于 2025-3-25 10:22:20

Submitted on: 20 July 2012. Revised on: 13 August 2012. Accepted on: 10 October 2012. ___________________Drug Design Development and Therapy

显示全部楼层 · 发表于 2025-3-25 12:28:54

Submitted on: 30 August 2023. Revised on: 24 October 2023. Accepted on: 13 December 2023. ___________________Drug Design Development and Therapy

显示全部楼层 · 发表于 2025-3-25 16:14:34

显示全部楼层 · 发表于 2025-3-25 20:26:25

显示全部楼层 · 发表于 2025-3-26 02:09:12

Submitted on: 19 June 2002. Revised on: 17 July 2002. Accepted on: 08 August 2002. ___________________Drug Design Development and Therapy

显示全部楼层 · 发表于 2025-3-26 08:01:16

Submitted on: 04 December 2020. Revised on: 11 January 2021. Accepted on: 27 February 2021. ___________________Drug Design Development and Therapy

显示全部楼层 · 发表于 2025-3-26 08:59:54

显示全部楼层 · 发表于 2025-3-26 14:56:38

显示全部楼层 · 发表于 2025-3-26 20:04:51

Submitted on: 05 April 2021. Revised on: 25 April 2021. Accepted on: 13 June 2021. ___________________Drug Design Development and Therapy

用户名		自动登录	找回密码
密码			To register

关于派博传思			派博传思旗下网站			友情链接
派博传思介绍	公司地理位置	论文服务流程	影响因子官网	SITEMAP	大讲堂	北京大学	Oxford Uni.	Harvard Uni.
发展历史沿革	期刊点评	投稿经验总结	SCIENCEGARD	IMPACTFACTOR	派博系数	清华大学	Yale Uni.	Stanford Uni.
\|Archiver\|手机版\|小黑屋\| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-1 09:27
Copyright © 2001-2015 派博传思京公网安备110108008328 版权所有 All rights reserved